Similarly, in the context of cardiometabolic diseases, miR-34a could promote the development of atherosclerosis by stimulating M1 polarization via liver X receptor α (LXRα), while the inhibition of miR-34a could help the regression of atherosclerosis and reversed the diet-induced metabolic disorder (64). Here, NR1H3 is linked to atherosclerosis.